QIAGEN N.V. Cash and Restricted Cash
QIAGEN N.V. (QGEN) had Cash and Restricted Cash of $839.00 million as of 2025-12-31, per its 20-F filed 2026-03-20.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-03-20
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $839.00M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $663.55M.
- 2023-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $668.08M.
- 2022-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $730.67M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | $839.00M 20-F · filed 2026-03-20 |
| 2024-12-31 | $663.55M 20-F · filed 2026-03-20 |
| 2023-12-31 | $668.08M 20-F · filed 2026-03-20 |
| 2022-12-31 | $730.67M 20-F · filed 2026-03-20 |
| 2021-12-31 | $880.52M 20-F · filed 2025-03-31 |
| 2020-12-31 | $597.98M 20-F · filed 2024-03-11 |
| 2019-12-31 | $629.39M 20-F · filed 2023-03-13 |
| 2018-12-31 | $1.16B 20-F · filed 2022-03-14 |
| 2017-12-31 | $657.71M 20-F · filed 2021-03-05 |
| 2016-12-31 | $439.18M 20-F · filed 2020-03-02 |